Early effects of corneal collagen cross-linking by iontophoresis in ex vivo human corneas
详细信息    查看全文
  • 作者:Rita Mencucci ; Stefano Ambrosini…
  • 关键词:Cross ; linking ; Iontophoresis ; Riboflavin ; Keratoconus ; Cornea
  • 刊名:Graefe's Archive for Clinical and Experimental Ophthalmology
  • 出版年:2015
  • 出版时间:February 2015
  • 年:2015
  • 卷:253
  • 期:2
  • 页码:277-286
  • 全文大小:1,992 KB
  • 参考文献:1. Wollensak G, Spoerl E, Seiler T (2003) Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135:620- CrossRef
    2. Wollensak G, Spoerl E, Mazzotta C et al (2011) Interlamellar cohesion after corneal crosslinking using riboflavin and ultraviolet a light. Br J Ophthalmol 95:876-0 CrossRef
    3. Zhang Y, Conrad AH, Conrad GW (2011) Effects of ultraviolet-a and riboflavin on the interaction of collagen and proteoglycans during corneal cross-linking. J Biol Chem 286:13011-2 CrossRef
    4. Wollensak G (2006) Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol 17:356-0 CrossRef
    5. Mazzotta C, Traversi C, Baiocchi S et al (2008) Corneal healing after riboflavin ultraviolet-A collagen cross-linking determined by confocal laser scanning microscopy in vivo: early and late modifications. Am J Ophthalmol 146:527-3 CrossRef
    6. Wollensak G, Spoerl E, Wilsch M, Seiler T (2004) Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment. Cornea 23:43- CrossRef
    7. Mencucci R, Marini M, Paladini I et al (2010) Effects of riboflavin/UVA corneal cross-linking on keratocytes and collagen fibres in human cornea. Clin Exp Ophthalmol 38:49-6 CrossRef
    8. Kohlhaas M, Spoerl E, Schilde T, Unger G, Wittig C, Pillunat LE (2006) Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet a light. J Cataract Refract Surg 32:279-3 CrossRef
    9. Wollensak G, Spoerl E, Seiler T (2003) Stress–strain measurements of human and porcine corneas after riboflavin ultraviolet- a-induced cross-linking. J Cataract Refract Surg 29:1780- CrossRef
    10. O’Brart D, Kwong TQ, Patel P, McDonald RJ, O’Brart NA (2013) Long-term follow-up of riboflavin/ultraviolet A (370?nm) corneal collagen cross-linking to halt the progression of keratoconus. Br J Ophthalmol 97:433-3 CrossRef
    11. Dhawan S, Rao K, Natrajan S (2011) Complications of corneal collagen cross-linking. J Ophthalmol 2011:869015
    12. Filippello M, Stagni E, Buccoliero D, Bomfiglio V, Avitabile T (2012) Transepithelial cross-linking in keratoconus patients: confocal analysis. Optom Vis Sci 89:1- CrossRef
    13. Caporossi A, Mazzotta C, Baiocchi S, Caporossi T, Paradiso AL (2012) Transepithelial corneal collagen crosslinking for keratoconus: qualitative investigation by in vivo HRT II confocal analysis. Eur J Ophthalmol 22:81- CrossRef
    14. Mencucci R, Paladini I, Sarchielli E, Favuzza E, Vannelli GB, Marini M (2013) Transepithelial riboflavin/ultraviolet. a corneal cross-linking in keratoconus: morphologic studies on human corneas. Am J Ophthalmol 156:874-4 CrossRef
    15. Filippello M, Stagni E, O’Brart D (2011) Transepithelial corneal collagen crosslinking: bilateral study. J Cataract Refract Surg 38:283-1 CrossRef
    16. Dixit N, Bali V, Baboota S, Ahuja A, Ali J (2007) Iontophoresis - an approach for controlled drug delivery: a review. Curr Drug Deliv 4:1-0
    17. Lam TT, Edward DP, Zhu XA, Tso MO (1989) Transscleral iontophoresis of dexamethasone. Arch Ophthalmol 107:1368-1
  • 刊物类别:Medicine
  • 刊物主题:Medicine & Public Health
    Ophthalmology
  • 出版者:Springer Berlin / Heidelberg
  • ISSN:1435-702X
文摘
Purpose The purpose was to investigate the early modifications induced by collagen cross-linking by iontophoresis of riboflavin (ionto-CXL) in ex vivo human corneas by evaluating different protocols of UVA irradiation. Methods In this experimental study 46 ex vivo human corneas obtained from the Eye Bank of Mestre (Italy) were divided in different groups: six were utilized as control (CTL); eight were treated with ionto-CXL at 3?mW/cm2 power for 30?min (I-3); eight were treated with ionto-CXL at 10?mW/cm2 for 9?min (I-10); eight were treated with iontophoretic delivery of riboflavin only (I-0); eight were treated with the standard CXL at 3?mW/cm2 for 30?min (S-3); and eight were treated with CXL at 10?mW/cm2 for 9?min (S-10). All samples were evaluated by haematoxylin-eosin staining and immunohistochemical analysis using different markers (Connexin 43, CD34, Collagen I, TUNEL assay). Western blot analysis, utilizing Bax and Ki67 primary antibodies, for detection of keratocyte apoptosis and proliferation, respectively, was also performed. Results No endothelial damage was evidenced in the treated groups. In I-10 corneas the epithelial layers were not always well-preserved. Anterior stroma showed an uneven distribution and numerical reduction of keratocytes as well as increased apoptosis; a reduced subepithelial interweaving of collagen I fibers was observed. In S-3 and S-10 the changes induced by treatments were similar to I-10. I-3 and I-0 showed no significant changes with respect to the control group. Conclusions In the ionto-CXL at 10?mW/cm2 group occurred the main morphological and biomolecular changes. This experimental study suggests that iontophoresis can be considered a non-invasive potential delivery tool for riboflavin penetration in corneal stroma during CXL.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700